ALS drug developer Coya upsizes proposed IPO to $32M, including warrants

2d illustrations and photos/iStock via Getty Images

ALS drug developer Coya Therapeutics (COYA) has disclosed terms for a proposed upsized $32M initial public offering.

Coya said in a filing that it plans to offer 3M shares with warrants to